Not Yet Recruiting
A Phase II Study of Benmelstobart + Anlotinib + Chemotherapy as First-Line Treatment for LCNEC and EP-NEC
NCT07510594
- Conditions
- Extrapulmonary Neuroendocrine Carcinoma, Large-Cell Neuroendocrine Carcinoma of the Lung
- Locations
-
- Tianjin Medical University Cancer Institute & Hospital Tianjin, Tianjin Municipality, China